APPENDIX 1
Submissions received by the Committee
|
1 |
Ms Lois Roberts |
|
2 |
Osteoporosis Australia |
|
3 |
National Pharmaceutical Services Association |
|
|
|
|
|
|
|
4 |
The Pharmacy Guild of Australia |
|
|
-
Supplementary
Submission received
19 October 2010
|
|
5 |
Breast Cancer Network Australia |
|
6 |
Medicines Australia |
|
|
-
Supplementary
Submission received
20 October 2010
|
|
7 |
DHL Supply Chain (Australia) Pty Ltd |
|
8 |
Generic Medicines Industry Association Pty Ltd |
|
|
-
Supplementary
Submission received
20 October 2010
|
|
9 |
Consumers Health Forum |
|
10 |
GlaxoSmithKline |
|
11 |
Aspen Pharmacare Australia Pty Ltd |
|
12 |
Sigma Pharmaceuticals |
|
13 |
Australian National University |
|
14 |
Spirit Pharmaceuticals Pty Ltd |
|
15 |
Bristol-Myers Squibb Australia |
|
16 |
Eli Lilly Australia Pty Ltd |
|
17 |
MSD |
|
18 |
Mr Edmund Fitzgerald and Mr Philip Clarke |
|
19 |
Confidential |
|
20 |
Hospira Pty Ltd |
|
21 |
Pfizer Australia |
|
22 |
Merck Serono Australia Pty Ltd |
|
23 |
Abbott Australasia Pty Ltd |
|
24 |
Novo Nordisk Pharmaceuticals |
|
25 |
Lundbeck Australia Pty Ltd |
|
26 |
Confidential |
|
27 |
Confidential |
|
28 |
Janssen-Cilag Pty Ltd |
|
29 |
Amgen Australia Pty Ltd |
|
30 |
National Prescribing Service |
|
31 |
Department of Health and Ageing |
|
32 |
Australian Pharmaceutical Industries Ltd |
Navigation: Previous Page | Contents | Next Page